Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy-Reference-Cited by-同舟云学术

Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy

Published:2019-06-13 Issue:6 Volume:17 Page:e3000286
ISSN:1545-7885
Container-title:PLOS Biology
language:en
Short-container-title:PLoS Biol

Author:

Lu Yun-Chi,Chuang Chih-Hung^ORCID,Chuang Kuo-Hsiang^ORCID,Chen I-Ju,Huang Bo-Cheng,Lee Wen-Han,Wang Hsin-Ell,Li Jia-Je,Cheng Yi-An,Cheng Kai-Wen,Wang Jaw-Yuan,Hsieh Yuan-Chin,Lin Wen-Wei,Cheng Tian-Lu^ORCID

Funder

Ministry of Science and Technology, Taiwan

National Health Research Institutes

Academia Sinica

Kaohsiung Medical University

Publisher

Public Library of Science (PLoS)

Subject

General Agricultural and Biological Sciences,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Reference48 articles.

1. Tumor necrosis factor (TNF) inhibitor therapy for rheumatoid arthritis;B Segal;Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics,2008

2. Anti-TNF therapy: past, present and future;C Monaco;International immunology,2015

3. Infliximab in the treatment of rheumatoid arthritis;A Perdriger;Biologics: targets & therapy,2009

4. Administration. FaD. Remicade (Infliximab): Highlights of prescribing information.: Food and Drug Administration.; 2011 https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/103772s5281lbl.pdf.

5. Administration FaD. Humira (Adalimumab): Highlights of prescribing information. 2008 https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/125057s114lbl.pdf.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fibroblast Activation Protein Is Expressed by Altered Osteoprogenitors and Associated to Disease Burden in Fibrous Dysplasia;Cells;2024-08-27

2. Integrating molecular dynamics simulation with small‐ and wide‐angle X‐ray scattering to unravel the flexibility, antigen‐blocking, and protease‐restoring functions in a hindrance‐based pro‐antibody;Protein Science;2024-08-15

3. Transcriptomic Signature and Pro-Osteoclastic Secreted Factors of Abnormal Bone-Marrow Stromal Cells in Fibrous Dysplasia;Cells;2024-04-30

4. Selective activation of IFNγ–ipilimumab enhances the therapeutic effect and safety of ipilimumab;International Journal of Biological Macromolecules;2024-04

5. Cell‐based therapies for the treatment of rheumatoid arthritis;Immunity, Inflammation and Disease;2023-11